These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23542086)

  • 21. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
    J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Dong H; Chen DQ; Wang Y; Li M
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF.
    O'Brien RJ; Squire IB; Demme B; Davies JE; Ng LL
    Eur J Heart Fail; 2003 Aug; 5(4):499-506. PubMed ID: 12921811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison study on diagnostic and prognostic value of N-terminal pro-brain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Li YJ; Wang L; Chen KY; Chen YL; Cai JR; Zhou LJ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):544-7. PubMed ID: 16146600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Midregional pro-atrial natriuretic peptide for the diagnosis of cardiac-related dyspnea according to renal function in the emergency department: a comparison with B-type natriuretic peptide (BNP) and N-terminal proBNP.
    Chenevier-Gobeaux C; Guerin S; André S; Ray P; Cynober L; Gestin S; Pourriat JL; Claessens YE
    Clin Chem; 2010 Nov; 56(11):1708-17. PubMed ID: 20813917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis of decompensated heart failure patients with preserved systolic function is predicted by NT-proBNP variations during hospitalization.
    Bettencourt P; Azevedo A; Fonseca L; Araújo JP; Ferreira S; Almeida R; Rocha-Goncalves F; Ferreira A
    Int J Cardiol; 2007 Apr; 117(1):75-9. PubMed ID: 16843555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Heart fatty acid binding protein in patients hospitalized because of worsening heart failure. Relation to prognosis of death].
    Mazovets OL; Trifonov IR; Katrukha AG; Bereznikova AV; Medvedeva MV; Deev AD; Gratsianksiĭ NA
    Kardiologiia; 2008; 48(1):24-9. PubMed ID: 18260992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single assay for amino-terminal fragments of cardiac A- and B-type natriuretic peptides.
    Ala-Kopsala M; Ruskoaho H; Leppäluoto J; Seres L; Skoumal R; Toth M; Horkay F; Vuolteenaho O
    Clin Chem; 2005 Apr; 51(4):708-18. PubMed ID: 15718490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.
    Michtalik HJ; Yeh HC; Campbell CY; Haq N; Park H; Clarke W; Brotman DJ
    Am J Cardiol; 2011 Apr; 107(8):1191-5. PubMed ID: 21296322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical studies on level of N-terminal portion of brain natriuretic in the treatment and prognosis of Chinese patients with chronic left heart failure].
    Wang F; Wang L; Bian WY; Xu ZM; Li YS
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Apr; 18(4):195-8. PubMed ID: 16647004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ProANP and NT-proBNP levels to prospectively assess cardiac function in breast cancer patients treated with cardiotoxic chemotherapy.
    Kouloubinis A; Kaklamanis L; Ziras N; Sofroniadou S; Makaritsis K; Adamopoulos S; Revela I; Athanasiou A; Mavroudis D; Georgoulias V
    Int J Cardiol; 2007 Nov; 122(3):195-201. PubMed ID: 17289172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure.
    van Kimmenade RR; Januzzi JL; Ellinor PT; Sharma UC; Bakker JA; Low AF; Martinez A; Crijns HJ; MacRae CA; Menheere PP; Pinto YM
    J Am Coll Cardiol; 2006 Sep; 48(6):1217-24. PubMed ID: 16979009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.
    Hartmann F; Packer M; Coats AJ; Fowler MB; Krum H; Mohacsi P; Rouleau JL; Tendera M; Castaigne A; Anker SD; Amann-Zalan I; Hoersch S; Katus HA
    Circulation; 2004 Sep; 110(13):1780-6. PubMed ID: 15381643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.
    Bettencourt P; Azevedo A; Pimenta J; Friões F; Ferreira S; Ferreira A
    Circulation; 2004 Oct; 110(15):2168-74. PubMed ID: 15451800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Admission and predischarge levels of NT pre brain natriuretic peptide in patients hospitalized because of worsening heart failure. relation to risk of death in the next 6-12 months].
    Mazovets OL; Trifonov IR; Katrukha AG; Gratsianskiĭ NA
    Kardiologiia; 2009; 49(1):34-8. PubMed ID: 19166399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
    Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
    Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natriuretic Peptides to Classify Risk of Atrial Fibrillation Detection After Stroke: Analysis of the BIOSIGNAL and PRECISE Cohort Studies.
    Cameron AC; Arnold M; Katsas G; Yang J; Quinn TJ; Abdul-Rahim AH; Campbell R; Docherty K; De Marchis GM; Arnold M; Kahles T; Nedeltchev K; Cereda CW; Kägi G; Bustamante A; Montaner J; Ntaios G; Foerch C; Spanaus K; Eckardstein AV; Dawson J; Katan M
    Neurology; 2024 Aug; 103(3):e209625. PubMed ID: 38950311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic value of N-terminal-pro-brain natriuretic peptide on admission in patients with chronic heart failure].
    Wang F; Li W; Huang J; Wang L; Bian WY; Pang HM; Wang Y; Xu ZM; Li YS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):28-32. PubMed ID: 16626545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: results from the International Collaborative of NT-proBNP Study.
    Mohammed AA; van Kimmenade RR; Richards M; Bayes-Genis A; Pinto Y; Moore SA; Januzzi JL
    Circ Heart Fail; 2010 May; 3(3):354-61. PubMed ID: 20332419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis of decompensated heart failure: role of NT-proBNP.
    Ferreira S; Almeida R; Guerrero H; Lourenço-Ferreira S; Fonseca L; Rocha R; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    Rev Port Cardiol; 2007 May; 26(5):535-45. PubMed ID: 17691279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.